Drug recall · January 22, 2020
Sumatriptan Succinate Tablets recall
Why: Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sumatriptan Succinate Tablets, 100 mg packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-69), Rx only, Sun Pharma, Cranbury, NJ
- Lots / codes
JKT4174A, exp. date 11/2021 JKU0622A, exp. date 01/2022 JKU1308A, exp. date 02/2022
- Quantity
- 207,585 blisters
- Company
- Sun Pharmaceutical Industries, Inc., Cranbury, NJ
- Distribution
- Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.
- Initiated
- December 26, 2019 · Voluntary: Firm initiated
- Classified
- January 13, 2020
- Reported
- January 22, 2020
- Ended
- October 22, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sumatriptan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.